PFS
AGIO icon

Prospera Financial Services’s Agios Pharmaceuticals AGIO Stock Holding History

Prospera Financial Services’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-75
Closed -$2K – 1630
2022
Q1 		$2K Buy
+75
New +$2.29K ﹤0.01% 2447

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Prospera Financial Services's AGIO Position: Q2 2022 in Review

Prospera Financial Services sold out of Agios Pharmaceuticals (AGIO) in Q2 2022, closing a stake of 75 shares — an estimated $2K sold.

Prospera Financial Services first reported a position in AGIO in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 155 funds tracked by Wall St. Rank hold AGIO as of Q2 2022.

  • Prospera Financial Services reported no remaining Agios Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 75 Agios Pharmaceuticals shares in Q2 2022, an estimated $2K.
  • Prospera Financial Services first reported a position in Agios Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • Prospera Financial Services's Agios Pharmaceuticals position peaked at $2K in Q1 2022.
  • 155 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.